Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Gunnarsson M, Malmeström C, Axelsson M, Sundström P, Dahle C, Vrethem M, Olsson T, Piehl F, Norgren N, Rosengren L, Svenningsson A, Lycke J.
Gunnarsson M, et al. Among authors: piehl f.
Ann Neurol. 2011 Jan;69(1):83-9. doi: 10.1002/ana.22247. Epub 2010 Dec 8.
Ann Neurol. 2011.
PMID: 21280078